Literature DB >> 12814912

Channels formed with a mutant prion protein PrP(82-146) homologous to a 7-kDa fragment in diseased brain of GSS patients.

Randa Bahadi1, Peter V Farrelly, Bronwyn L Kenna, Joseph I Kourie, Fabrizio Tagliavini, Gianluigi Forloni, Mario Salmona.   

Abstract

A major prion protein (PrP) mutant that forms amyloid fibrils in the diseased brain of patients with Gerstmann-Sträussler-Scheinker syndrome (GSS) is a fragment of 7 kDa spanning from residues 81-82 to 144-153 of PrP. Analysis of ionic membrane currents, recorded with a lipid bilayer technique, revealed that the wild-type fragment PrP(82-146) WT and the partially scrambled PrP(82-146) (127-146) SC are capable of forming heterogeneous ion channels that are similar to those channels formed with PrP(106-126). In contrast, PrP(82-146) peptides in which the region from residue 106 to 126 had been scrambled (SC) showed a reduction in interaction with lipid membranes and did not form channels. The PrP(82-146) WT- and PrP(82-146) (127-146) SC-formed cation channels with fast kinetics are Cu2+ sensitive and rifampicin (RIF) insensitive, whereas the time-dependent inactivating channels formed by these same peptides are both Cu2+ and RIF insensitive. The presence of RIF in the solution before the addition of PrP(82-146) WT or PrP(82-146) (127-146) SC affected their incorporation into the lipid bilayers. PrP(82-146) WT and PrP(82-146) (127-146) SC fast cation channels formed in the presence of RIF appeared in an electrically semisilent state or an inactivated state. Increasing [Cd2+]cis enhanced the incorporation of PrP(82-146) WT and PrP(82-146) (127-146) SC channels formed in the presence of RIF. We conclude that the major PrP mutant fragment in the diseased brain of GSS patients is prone to form channels in neuronal membranes, causing their dysfunction. We propose that Cd2+ may accentuate the neurotoxicity of this channel-forming PrP fragment by enhancing its incorporation into the membrane.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12814912     DOI: 10.1152/ajpcell.00077.2003

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  11 in total

Review 1.  Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi.

Authors:  Vladimir N Uversky; Alexander V Kabanov; Yuri L Lyubchenko
Journal:  J Proteome Res       Date:  2006-10       Impact factor: 4.466

Review 2.  Implications of peptide assemblies in amyloid diseases.

Authors:  Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Kakinen; Ibrahim Javed; Frances Separovic; Thomas P Davis; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

Review 3.  Antimicrobial properties of amyloid peptides.

Authors:  Bruce L Kagan; Hyunbum Jang; Ricardo Capone; Fernando Teran Arce; Srinivasan Ramachandran; Ratnesh Lal; Ruth Nussinov
Journal:  Mol Pharm       Date:  2011-11-29       Impact factor: 4.939

4.  β-amyloid oligomers and prion protein: Fatal attraction?

Authors:  Gianluigi Forloni; Claudia Balducci
Journal:  Prion       Date:  2011-01-01       Impact factor: 3.931

Review 5.  Amyloid peptide channels.

Authors:  B L Kagan; R Azimov; R Azimova
Journal:  J Membr Biol       Date:  2004-11       Impact factor: 1.843

Review 6.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

7.  Neurotoxic and gliotrophic activity of a synthetic peptide homologous to Gerstmann-Sträussler-Scheinker disease amyloid protein.

Authors:  Luana Fioriti; Nadia Angeretti; Laura Colombo; Ada De Luigi; Alessio Colombo; Claudia Manzoni; Michela Morbin; Fabrizio Tagliavini; Mario Salmona; Roberto Chiesa; Gianluigi Forloni
Journal:  J Neurosci       Date:  2007-02-14       Impact factor: 6.167

8.  The Pathogenic A116V Mutation Enhances Ion-Selective Channel Formation by Prion Protein in Membranes.

Authors:  Ambadi Thody Sabareesan; Jogender Singh; Samrat Roy; Jayant B Udgaonkar; M K Mathew
Journal:  Biophys J       Date:  2016-04-26       Impact factor: 4.033

9.  In vitro and in vivo neurotoxicity of prion protein oligomers.

Authors:  Steve Simoneau; Human Rezaei; Nicole Salès; Gunnar Kaiser-Schulz; Maxime Lefebvre-Roque; Catherine Vidal; Jean-Guy Fournier; Julien Comte; Franziska Wopfner; Jeanne Grosclaude; Hermann Schätzl; Corinne Ida Lasmézas
Journal:  PLoS Pathog       Date:  2007-08-31       Impact factor: 6.823

10.  Neurotoxicity of prion peptides mimicking the central domain of the cellular prion protein.

Authors:  Silvia Vilches; Cristina Vergara; Oriol Nicolás; Gloria Sanclimens; Sandra Merino; Sonia Varón; Gerardo A Acosta; Fernando Albericio; Miriam Royo; José A Del Río; Rosalina Gavín
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.